Sangamo Therapeutics (LTS:0R1D) Dividend Payout Ratio: (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0R1D Sangamo Therapeutics Inc LTS:0R1D
41 GF Score
Price $0.14
GF Value $12.39
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Sangamo Therapeutics Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Sangamo Therapeutics's Dividend Payout Ratio for the months ended in Mar. 2026 was .

The historical rank and industry rank for Sangamo Therapeutics's Dividend Payout Ratio or its related term are showing as below:


LTS:0R1D's Dividend Payout Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 0.4
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2026-09-22), the Dividend Yield % of Sangamo Therapeutics is 0.00%.

Sangamo Therapeutics's Dividends per Share for the months ended in Mar. 2026 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Sangamo Therapeutics (LTS:0R1D) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Sangamo Therapeutics Dividend Payout Ratio Related Terms

Sangamo Therapeutics Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Sangamo Therapeutics's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sangamo Therapeutics Dividend Payout Ratio Chart

Sangamo Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sangamo Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

LTS:0R1D vs EXOZ, RNTX, ALPS: Dividend Payout Ratio Comparison

For the Biotechnology subindustry, Sangamo Therapeutics's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sangamo Therapeutics Dividend Payout Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sangamo Therapeutics's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Sangamo Therapeutics's Dividend Payout Ratio falls into.


LTS:0R1D
41GF Score
Sangamo Therapeutics Inc LTS:0R1D
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sangamo Therapeutics Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Sangamo Therapeutics's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=0/ -0.40567573065708
=N/A

Sangamo Therapeutics's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=0/ -0.079552687774629
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Sangamo Therapeutics (LTS:0R1D) Overvalued in 2026?

Based on GuruFocus' analysis, Sangamo Therapeutics stock appears to be undervalued. The current stock price of $0.14 is trading 98.9% below its estimated GF Value™ of $12.39. GuruFocus considers Sangamo Therapeutics to be Possible Value Trap.

Key valuation signals for LTS:0R1D:

  • Dividend Payout Ratio:
  • GF Value™: $12.39 vs. price of $0.14 (98.9% below fair value)
  • GF Score™: 41/100 with 6 warning signs

No single metric tells the full story. See the LTS:0R1D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sangamo Therapeutics Business Description

Other Exchanges SGMO:USAGBY:Germany
Address 501 Canal Boulevard, Richmond, CA, USA, 94804
Sangamo Therapeutics Inc. is a clinical-stage genomic medicine company based in the United States. It develops engineered zinc finger proteins and other gene-editing and gene-regulation technologies to create treatments for serious genetic and neurological diseases. Its pipeline spans epigenetic regulation therapies, engineered adeno-associated virus (AAV) capsids for targeted delivery to the central nervous system, and gene therapies for conditions such as Fabry disease, hemophilia A, and neurological disorders including prion disease, tauopathies, ALS/FTD, and Huntington's disease. Sangamo also pursues ex vivo cell therapy programs, including CAR-Treg approaches for autoimmune and inflammatory conditions. The company generates revenue primarily through collaboration and license agreements with pharmaceutical partners, including milestone payments and royalties, alongside research funding, rather than from marketed products, as it has no approved medicines. Its activities are concentrated in the United States, with partnerships extending to international biopharmaceutical collaborators.
41GF Score

Get the complete analysis for LTS:0R1D

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.14
Price
$12.39
GF Value